Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Clin Cancer Res. 2019 Jul 29;25(20):6089–6097. doi: 10.1158/1078-0432.CCR-19-0208

Fig. 4.

Fig. 4.

Overall survival according to CTC enumeration in patients with 5–19 vs ≥20 CTC/7.5 ml WB at baseline using the revised algorithm. 4A. OS for patients with 5–19 vs. ≥20 CTC/7.5 ml WB; 4B. OS of patients with 5–19 CTC/7.5 ml WB divided by doublets or clusters vs. no doublets or clusters; 4C. OS of patients with ≥20 CTC/7.5 ml WB divided by doublets or clusters vs no doublets or cluster.